Hepatitis B in Moroccan blood donors: A decade trend of the HBsAg prevalence in a resources limited country

Transfusion Medicine

Volumn 23, Issue 6, 2013, Pages 432-437

  Adouani, B ^a,b   Alami, R ^a   Laouina, A ^a,b   Benahadi, A ^a,b   Boulahdid, S ^a,b   Mokhtari, A ^b   Soulaymani, A ^b   Abouyoub, A ^a   Benajiba, M ^a  

^a IBN SINA HOSPITAL   (Morocco)

^b IBN TOFAIL UNIVERSITY   (Morocco)

Author keywords

Blood donors; Developing country; Hepatitis B; Morocco; Prevalence

Indexed keywords

HEPATITIS B SURFACE ANTIGEN;

ADULT; ARTICLE; BLOOD DONOR; BLOOD TRANSFUSION; BLOOD TRANSFUSION REACTION; DEVELOPING COUNTRY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; INFECTIOUS COMPLICATION; MAJOR CLINICAL STUDY; MALE; MOROCCO; NONHUMAN; PREVALENCE; SEROCONVERSION; SEROPREVALENCE; VIRUS HEPATITIS;

BLOOD DONORS; DEVELOPING COUNTRY; HEPATITIS B; MOROCCO; PREVALENCE;

ADOLESCENT; ADULT; BLOOD DONORS; BLOOD TRANSFUSION; FEMALE; HEPATITIS B; HEPATITIS B SURFACE ANTIGENS; HUMANS; MALE; MOROCCO; RETROSPECTIVE STUDIES; SEROEPIDEMIOLOGIC STUDIES;

EID: 84888384066     PISSN: 09587578     EISSN: 13653148     Source Type: Journal    
DOI: 10.1111/tme.12054     Document Type: Article

References (37)

1. Ado, A., Alhassan, S., Chonoko, U.G. & Samaila, A.U. (2010) Sero-prevalence of hepatitis B surface antigen (Hbsag) among blood donors attending Ahmadu Bello University Teaching Hospital (Abuth), Zaria, Nigeria. Bayero Journal of Pure and Applied Sciences, 3, 20-22.
2. Adoga, M.P., Gyar, S.D., Pechulano, S., Bashayi, O.D., Emiasegen, S.E., Zungwe, T., Iperepolu, O.H., Agupugo, C. & Agwale, S.M. (2010) Hepatitis B virus infections in apparently healthy urban Nigerians: data from pre-vaccination tests. J Infect Dev Ctries, 4, 397-400.
3. Allain, J.P. (2010) Volunteer safer than replacement donor blood: a myth revealed by evidence. International Society of Blood Transfusion: ISBT Science Series, 5, 169-175.
4. Allain, J.P., Sarkodie, F., Asenso-Mensah, K. & Owusu-Ofori, S. (2009) Relative safety of first-time volunteer and replacement donors in west Africa. Transfusion, 50, 340-343.
5. Alter, M.J., Kruszon-Moran, D., Nainan, O.V., McQuillan, G.M., Gao, F., Moyer, L.A., Kaslow, R.A. & Margolis, H.S. (1999) The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. The New England Journal of Medicine, 341, 556-562.
6. Annuaire Statistique du MAROC (2010) Haut Commissariat au Plan, Division de la Statistique. Générale, dépôt légale: 2008/2616. 21, 22, 421, 438-446.
7. Baha, W., Foullous, A., Dersi, N. et al. (2013) Prevalence and risk factors of hepatitis B and C virus infections among the general population and blood donors in Morocco. BMC Public Health. DOI: 10.1186/1471-2458-13-50.
8. Barkat, A., Braikat, M., Lamdaouar Bouazzaoui, N. (2008) Calendrier National de Vaccination: évolution et perspectives. www.santemaghreb.com (Accessed 09/07/2012).
9. Busch, M.P., Glynn, S.A., Stramer, S.L., Strong, D.M., Caglioti, S., Wright, D.J., Pappalardo, B. & Kleinman, S.H. (2005) A new strategy for estimating risks of transfusion-transmitted viral infections based on rates of detection of recently infected donors. Transfusion, 45, 254-264.
10. Busch, P.M. (2000) HIV, HBV and HCV: new development related to transfusion safety. Vox Sanguinis, 78, 253-256.
11. Comanor, L. & Holland, P. (2006) Hepatitis B virus blood screening: unfinished agendas. Vox Sanguinis, 91, 1-12.
12. Dodd, R.Y., Notari, E.P. & Stramer, S.L. (2002) Current prevalence and incidence of infectious disease markers and estimated window-period risk in the American Red Cross blood donor population. Transfusion, 42, 975-979.
13. Glynn, S.A., Kleinman, S.H., Schreiber, G.B., Busch, M.P., Wright, D.J., Smith, J.W., Nass, C.C. & Williams, A.E. (2000) Trends in incidence and prevalence of major transfusion-transmissible viral infections in US blood donors, 1991 to 1996. Retrovirus epidemiology Donor Study (REDS). JAMA, 284, 229-235.
14. Dilsiz, G., Yenicesu, I., Belen, F.B., Celik, B. & Ozturk, G. (2012) Trends in hepatitis B and hepatitis C virus seropositivity among blood donors over 15 years screened in the blood bank of a university hospital. Transfusion and Apheresis Science, 47, 95-100.
15. Hajrullah, F. & Skender, T. (2009) Prevalence of HBV and HCV among blood donors in Kosovo. Virology Journal, 6, 21.
16. Kamal, M.S., Mahmoud, S., Hafez, T. & EL-Fouly, R. (2010) Viral hepatitis A to E in South Mediterranean countries. Mediterranean Journal of Hematology and Infectious Diseases, 2, e2010001.
17. Laouina, A., Abouyoub, A., Soulaymani, A. & Alami, R. (2012) Alanine transaminase level in a healthy population in Morocco. Pakistan Journal of Biological Sciences, 15, 238-243. DOI: 10.3923/pjbs.2012.238.243.
18. Lavanya, V., Viswanathan, T., Arul Sheeba Malar, S., Malarvizhi, A. & Moorthy, K. (2012) Prevalence of hepatitis B virus infection among blood donors with antibodies to hepatitis B core antigen. International Journal of Medicine and Medical Sciences, 4, 128-137. DOI: 10.5897/IJMMS12.011.
19. Matee, M.I., Lyamuya, E.F., Mbena, E.C., Magessa, P.M., Sufi, J. & Marwa, G.J. (1999) Prevalence of transfusion-associated viral infections and syphilis among blood donors in Muhimbili Medical Centre, Dar es Salaam, Tanzania. East African Medical Journal, 76, 167-171.
20. Moroccan Law (1995) Moroccan laws related to blood donation and use of human blood. Dahir n° 1-95-133. (BO N° 4323 du 6-9-1995).
21. Mujeeb, S.A. & Mark, S. (2007) Pearce seroprevalence and determinants of risk of hepatitis B and C viral infections in blood donors: a cross sectional analytic study. Journal of Infection in Developing Countries, 1, 17-24.
22. Nantachit, N., Robison, V., Wongthanee, A., Kamtorn, N., Suriyanon, V. & Nelson, K.E. (2003) Temporal trends in the prevalence of HIV and other transfusion-transmissible infections among blood donors in northern Thailand, 1990 through 2001. Transfusion, 43, 730-735.
23. Plaquettes du CNTS. (2009) Système Transfusionnel Marocain 2, 3
24. Référentiel des Bonnes Pratiques Transfusionnelles (2004). Guidelines for good blood transfusion manufacturing practices, CNTS, Morocco, 15-24.
25. Référentiel des Bonnes Pratiques Transfusionnelles (2006). Guidelines for good blood transfusion manufacturing practices, CNTS, Morocco, 15-24.
26. Référentiel des Bonnes Pratiques Transfusionnelles (2009). Guidelines for good blood transfusion manufacturing practices, CNTS, Morocco, 15-24.
27. Rouibaa, F., Acharki, M., Amrani, L., Serraj, L., Bennani, M., Kanouni, N., Abouqual, R. & Amrani, N. (2008) Prevalence of hepatitis B and C markers in high risk hospitalized patients in Morocco. Arab Journal of Gastroenterology, 9, 70-74.
28. Santé en chiffre (2010) Direction de la Planification et des Ressources Financières Division de la Planification et des Etudes. Service des Etudes et de l'Information Sanitaire. Ministère de la Santé. Royaume du MAROC http://srvweb.sante.gov.ma/Publications/Etudes_enquete/Documents/SC2011.pdf (Accessed 9/7/12).
29. Sbai, A., Baha, W., Ougabrai, H. et al. (2012) Hepatitis B prevalence and risk factors in Morocco. Pathologie Biologie (Paris).
30. Schreiber, G.B., Busch, P.M., Kleinman, S.H. & Korelitz, J.J. (1996) The risk of transfusion transmitted viral infection. New England Journal of Medicine, 334, 1685-1690.
31. Soldan, K., Barbara, J.A.J. & Dow, B.C. (2002) Transfusion transmitted hepatitis B virus infection in the UK: a small and moving target. Vox Sanguinis, 83, 305-308.
32. Tazi-Mokha, A., Soulaymani, A., Mokhtari, A. & Alami, R. (2012) Blood donation in Morocco: a 20-year retrospective study of blood collection in the Rabat blood centre. Transfusion Medicine, 22, 173-180.
33. Triki, H., Said, N., Ben Salah, A. et al. (1997) Seroepidemiology of hepatitis B, C and delta viruses in Tunisia. Transactions of the Royal Society of Tropical Medicine and Hygiene, 91, 11-14.
34. Wasfi, O.A. & Sadek, N.A. (2011) Prevalence of hepatitis B surface antigen and hepatitis C virus antibodies among blood donors in Alexandria, Egypt. Eastern Mediterranean Health Journal, 17, 238-242.
35. Weusten, J., Vermeulen, M., van Drimmelen, H. & Lelie, N. (2011) Refinement of a viral transmission risk model for blood donations in seroconversion window phase screened by nucleic acid testing in different pool sizes and repeat test algorithms. Transfusion, 51, 203-215.
36. World Health Organization 2001. Hepatitis. World Health Organization. Introduction of hepatitis B vaccine into childhood immunization services. Management guidelines, including information for health workers and parents. Geneva, WHO. URL http://www.who.int/vaccines-documents/DocsPDF01/www613.pdf. Accessed on 09/07/2012.
37. Zou, S.H., Notari, E.P., Stramer, S.L., Wahab, F., Musavi, F. & Dodd, R.Y. (2004) Pattern of age- and sex-specific prevalence of major blood-borne infections in United States blood donors, 1995 to 2002: American Red Cross blood donor study. Transfusion, 44, 1640-1647.